LH:NYSE
LabCorp
366,57 USD
arrow_upward
+0,90%(+3,27) 1G
366,57 USD
0,00% (0,00)
bedtimeAfter Hours
Chiusura: 6 nov, 16:00:04 GMT-5 · USD
search
Tutti i simboli
| Simbolo | Prezzo | Cambio | % di cambio |
|---|
insights_autoGenerazione degli insight principali per LH in corso…
Apertura
357,25 USD
Massimo
369,06 USD
Minimo
355,63 USD
Cap. mercato
29,77 Mld
Vol. medio
741,31K
Volume
610,11K
Dividendo
0,79%
Dividendo trimestrale
0,72 USD
Data di stacco dividendo
29 mag 2026
Rapporto P/E
30,06
Max 52 sett.
371,00 USD
Min 52 sett.
244,52 USD
Utili per azione
12,19 USD
Beta
0,87
Azioni in circolazione
81,20 Mln
N. di dipendenti
71K
Apertura
357,25 USD
Massimo
369,06 USD
Minimo
355,63 USD
Cap. mercato
29,77 Mld
Vol. medio
741,31K
Volume
610,11K
Dividendo
0,79%
Dividendo trimestrale
0,72 USD
Data di stacco dividendo
29 mag 2026
Rapporto P/E
30,06
Max 52 sett.
371,00 USD
Min 52 sett.
244,52 USD
Utili per azione
12,19 USD
Beta
0,87
Azioni in circolazione
81,20 Mln
N. di dipendenti
71K
Articoli giornalistici
Da fonti web e partner giornalistici
Investing.com
·
1 giorno fa
Labcorp evp Bryan Vaughn sells $108,232 in shares
Yahoo Finance
·
1 giorno fa
OPKO Health Inc (OPK) (Q3 2026) Earnings Call Highlights: Revenue Climbs 16% as LabCorp Deal ...
Profilo
Labcorp Holdings Inc., operating under the brand name Labcorp, headquartered in Burlington, North Carolina, provides laboratory services used for diagnosis and healthcare decisions. It operates one of the largest clinical laboratory networks in the world and has operations in over 100 countries; although its operations are primarily in the U.S.
Its Diagnostics Laboratories segment operates 2,000 patient service centers with more than 6,000 in-office phlebotomists in the United States. In addition to healthcare testing such as oncology testing, human immunodeficiency virus genotyping and phenotyping, it provides testing for: employment, DNA testing to determine parentage and to determine immigration eligibility, environmental issues, wellness, toxicology, pain management, and medical drug monitoring. It also provides 50 tests that patients can complete at home. It processes over 160 million tests per year. Approximately 10% of this segment’s revenue are from the U.S. Medicare health insurance program. Wikipedia
Informazioni su LabCorp
CEOAdam H. Schechter
Dipendenti71K
Data di fondazione1978
SedeBurlington, Carolina del Nord, Stati Uniti
SettoreHealth Care
Settore-
Sito weblabcorp.com